Cargando…

Cost-Effectiveness Evaluation of Quadrivalent Human Papilloma Virus Vaccine for HPV-Related Disease in Iran

Human Papilloma Virus (HPV) vaccine has been added recently to the Iran Drug List. So, decision makers need information beyond that available from RCTs to recommend funding for this vaccination program to add it to the National Immunization program in Iran. Modeling and economic studies have address...

Descripción completa

Detalles Bibliográficos
Autores principales:	Khatibi, Mohsen, Rasekh, Hamid Reza, Shahverdi, Zohreh, jamshidi, Hamid Reza
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Shaheed Beheshti University of Medical Sciences 2014
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3977074/ https://www.ncbi.nlm.nih.gov/pubmed/24711850

Ejemplares similares

Applying a Simple Model of Cost Effectiveness Study of HPV Vaccine for Iran
por: Khatibi, Mohsen, et al.
Publicado: (2015)

An Evaluation of the Cost of Human Papilloma Virus (HPV) Vaccine Delivery In Zambia
por: Simuyemba, Moses C, et al.
Publicado: (2023)

Costs of Treatment after Renal Transplantation: Is it Worth to Pay More?
por: Salamzadeh, Jamshid, et al.
Publicado: (2014)

Low Prevalence of Human Papilloma Virus in Patients with Breast Cancer, Kerman; Iran
por: Afshar, Reza Malekpour, et al.
Publicado: (2018)

Cost-Effectiveness of Bivalent, Quadrivalent, and Nonavalent HPV Vaccination in South Africa
por: Michaeli, Daniel Tobias, et al.
Publicado: (2022)

Neuromyotonia with Central Nervous System Lesions following Quadrivalent Human Papilloma Virus Vaccination
por: Hatami, Maryam, et al.
Publicado: (2022)

The effect of history of abnormal pap smear or preceding HPV infection on the humoral immune response to Quadrivalent Human Papilloma virus (qHPV) vaccine in women with systemic lupus erythematosus
por: Dhar, J. Patricia, et al.
Publicado: (2018)

An Update on Human Papilloma Virus Vaccines: History, Types, Protection, and Efficacy
por: Yousefi, Zahra, et al.
Publicado: (2022)

Cost of Preventing, Managing, and Treating Human Papillomavirus (HPV)-Related Diseases in Sweden before the Introduction of Quadrivalent HPV Vaccination
por: Östensson, Ellinor, et al.
Publicado: (2015)

Ongoing inadequacy of quadrivalent HPV vaccine safety studies
por: Little, Deirdre T, et al.
Publicado: (2020)

Cost-utility analysis of immune tolerance induction therapy versus on-demand treatment with recombinant factor VII for hemophilia A with high titer inhibitors in Iran
por: Rasekh, Hamid Reza, et al.
Publicado: (2011)

Cost-effectiveness of vaccination with a quadrivalent HPV vaccine in Germany using a dynamic transmission model
por: Schobert, Deniz, et al.
Publicado: (2012)

Evaluation of HPV DNA positivity in colorectal cancer patients in Kerman, Southeast Iran
por: Afshar, Reza Malekpour, et al.
Publicado: (2018)

Evaluation of immune response to single dose of quadrivalent HPV vaccine at 10-year post-vaccination
por: Joshi, Smita, et al.
Publicado: (2023)

Human papilloma virus 16/18 genotypes in patients with squamous cell carcinoma of cervix in northeast Iran
por: Ayatollahi, Hossein, et al.
Publicado: (2014)

Administrative Process and Criteria Ranking for Drug Entering Health Insurance List in Iran-TOPSIS-Based Consensus Model
por: Viyanchi, Amir, et al.
Publicado: (2016)

Prevalence of human papilloma virus (HPV) genotypes between outpatients males and females referred to seven laboratories in Tehran, Iran
por: Rezaee Azhar, Iman, et al.
Publicado: (2022)

Public knowledge and attitudes towards Human Papilloma Virus (HPV) vaccination
por: Walsh, Charlotte Devereaux, et al.
Publicado: (2008)

Selecting the Acceptance Criteria of Medicines in the Reimbursement List of Public Health Insurance of Iran, Using the “Borda” Method: a Pilot Study
por: Viyanchi, Amir, et al.
Publicado: (2015)

Effectiveness of quadrivalent HPV vaccination in reducing vaccine-type and nonvaccine-type high risk HPV infection
por: Li, Chenxi, et al.
Publicado: (2023)

The patent buyout price for human papilloma virus (HPV) vaccine and the ratio of R&D costs to the patent value
por: Songane, Mario, et al.
Publicado: (2021)

Immunological response to quadrivalent HPV vaccine in treatment of recurrent respiratory papillomatosis
por: Tjon Pian Gi, Robin E. A., et al.
Publicado: (2016)

Modelling the effects of quadrivalent Human Papillomavirus (HPV) vaccination in Puerto Rico
por: Ortiz, Ana Patricia, et al.
Publicado: (2017)

Quadrivalent HPV vaccine safety review and safety monitoring plans for nine-valent HPV vaccine in the United States
por: Gee, Julianne, et al.
Publicado: (2016)

Evaluating the Early Benefit of Quadrivalent HPV Vaccine on Genital Warts in Belgium: A Cohort Study
por: Dominiak-Felden, Geraldine, et al.
Publicado: (2015)

Knowledge of Cervical Cancer, Human Papilloma Virus (HPV) and HPV Vaccination Among Women in Northeast China
por: Ning, Yu-e, et al.
Publicado: (2019)

Knowledge of human papilloma virus (HPV), HPV-vaccine and pap smear among adult Saudi women
por: Al Ghamdi, Nada H.
Publicado: (2022)

Association of human papilloma virus (HPV) infection with oncological outcomes in urothelial bladder cancer
por: Ohadian Moghadam, Solmaz, et al.
Publicado: (2020)

“Saving lives”: Adapting and adopting Human Papilloma Virus (HPV) vaccination in Austria
por: Paul, Katharina T.
Publicado: (2016)

Mothers of adolescent girls and Human Papilloma Virus (HPV) vaccination in Western Kenya
por: Mabeya, Hillary, et al.
Publicado: (2021)

Perception of human papilloma virus (HPV) vaccination during the COVID-19 pandemic
por: Jung, Ye Won, et al.
Publicado: (2022)

Association of Human Papilloma Virus and Epstein-Barr Virus with Ovarian Cancer in Shiraz, Southwestern Iran
por: Shokouh, Mohammad Reza, et al.
Publicado: (2020)

L1 Recombinant Proteins of HPV Tested for Antibody Forming Using Sera of HPV Quadrivalent Vaccine
por: Akuzum, Begum, et al.
Publicado: (2018)

Post Marketing Surveillance Study of 2(nd) Dose Quadrivalent Human Papilloma Virus Vaccine in Elementary School Children in Jakarta, Indonesia: Safety Result and Implementation of School-Based HPV Immunization Program
por: Satari, Hindra Irawan, et al.
Publicado: (2019)

Is prostatic adenocarcinoma in a relationship with Human Papilloma Virus in Isfahan -Iran
por: Mokhtari, Mojgan, et al.
Publicado: (2013)

The epidemiological and economic impact of a quadrivalent human papillomavirus (hpv) vaccine in Estonia
por: Uusküla, Anneli, et al.
Publicado: (2013)

Correction: Modelling the effects of quadrivalent Human Papillomavirus (HPV) vaccination in Puerto Rico
por: Ortiz, Ana Patricia, et al.
Publicado: (2018)

The quadrivalent HPV vaccine is protective against genital warts: a meta-analysis
por: Lukács, Anita, et al.
Publicado: (2020)

Cost–effectiveness analysis of quadrivalent influenza vaccine in Spain
por: García, Amos, et al.
Publicado: (2016)

The Cost-Effectiveness of Quadrivalent Human Papillomavirus Vaccination in Indonesia
por: Kosen, Soewarta, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_b6bphqljlooocvs4sghd91h92e